MFDS — authorised 4 August 2023
- Marketing authorisation holder: SAGE THERAP
- Status: likely_approved
🇰🇷 Zurzuvae in South Korea
MFDS authorised Zurzuvae on 4 August 2023
Marketing authorisation
Zurzuvae in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Neuroscience approved in South Korea
Frequently asked questions
Is Zurzuvae approved in South Korea?
Yes. MFDS authorised it on 4 August 2023.
Who is the marketing authorisation holder for Zurzuvae in South Korea?
SAGE THERAP holds the South Korean marketing authorisation.